NCT01340820View on ClinicalTrials.gov

Study of AERAS 422 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

May 31, 2012

Conditions

Tuberculosis

Interventions

DRUG

AERAS-422

rBCG

DRUG

BCG Tice

1-8 x 10\^5 CFU

Trial Locations (1)

63104

St. Louis University Hospital, St Louis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Aeras

OTHER